Amid Scarcity and Soaring Prices, China Could Issues Compulsory License for Paxlovid 09/02/2023 Zhenyan Zhu, Yuanqiong Hu & Guangjian Xue After three years of its “Zero COVID” policy, the Chinese government allowed a return to relative normalcy for its citizens in early December 2022. Due to the ongoing transmission of Omicron and its numerous COVID subvariants in China, the sudden policy shift was accompanied by rapid community transmission across the country and high numbers of […] Continue reading ->